The Ohio State University

Gahanna, Ohio 43230

1 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Cutaneous Squamous Cell Carcinoma, EGFR Inhibitor-associated Rash, Psoriasis

Studies at this site

• A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity — Recruiting now
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed